Spectral Medical Inc.

TSX:EDT.TO

Medical - Diagnostics & Research

Healthcare
$1.04 -1.45%

-$0.02 today

Market cap
$306.00M
Beta
0.23
P/E (TTM)
-10.5
EPS (TTM)
-$0.13
52W Low $0.77High $1.84

Volume 0.02M

Average 0.06M

EDT.TO EBITDA Margin

EBITDA as a percentage of revenue.

Spectral Medical Inc.TSX: EDT.TO

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin widens to -372.7%

EBITDA Margin was -372.7% in Q1 FY2026, up 1630.6 pp from a year earlier. On a trailing-twelve-month basis it was -1275.3%, down 390.0 pp year over year. Over 3 fiscal years it narrowed by 37.5 pp.

Context

  • EBITDA Margin widened in 2 of the last 3 fiscal years.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 1 analysts of 142.1% for the fiscal year ending Dec 2026, up from -468.3% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-372.7%+230.9 pp QoQ
Last fiscal yearDec 2025
-468.3%+55.2 pp YoY
LTMMar 2026
-1275.3%-390.0 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+1630.6 pp-184.9 pp-1815.4 pp
1 year+55.2 pp+610.3 pp+555.1 pp
3 years-37.5 pp+523.9 pp+561.5 pp
5 years+529.8 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
-468.3%
Year-over-year change
+55.2pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How EDT.TO compares with its peers on the latest reported figures

  • EDT.TO's LTM Mar 2026 EBITDA Margin of -1275.3% is the lowest of the 7 companies compared; the peer median is -3.7%.
  • Its year-over-year change of -390.0 pp is the lowest of 7, against a peer median of +19.9 pp.
  • Over three fiscal years its change of -37.5 pp compares with a peer median of +92.5 pp.
EDT.TO Competitors Peer median
EBITDA Margin for EDT.TO and competitors
Company Period LTM level YoY 3-year change
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 202649.3% +16.9 pp-11.3 pp
KSI.TOKneat.com, Inc.LTM Mar 202619.0% -5.2 pp+22.3 pp
ACB.TOAurora Cannabis Inc.LTM Mar 20263.1% -11.9 pp+39.6 pp
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026-10.5% +23.0 pp+1464.5 pp
WEED.TOCanopy Growth CorporationLTM Mar 2026-20.4% +157.8 pp+798.1 pp
PRN.TOProfound Medical Corp.LTM Mar 2026-194.3% +121.3 pp+145.4 pp
EDT.TOSpectral Medical Inc.LTM Mar 2026-1275.3% -390.0 pp-37.5 pp
EPRX.TOEupraxia Pharmaceuticals Inc.FY2025— ——
Peer median (excluding EDT.TO) -3.7%+19.9 pp+92.5 pp

Competitors are the stored peer set for EDT.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2M1.67M1.6M2.29M2.44M
Cost of Revenue832K684K936K1.27M7.6M
Gross Profit1.16M983K662K1.02M(5.16M)
Gross Margin58.3%59.0%41.4%44.5%-211.1%
Research & Development004.68M3.97M4.33M
Selling, General & Admin7.01M8.64M11.29M11.62M11.73M
Operating Expenses7.86M9.43M12.08M13.02M6.53M
Depreciation & Amortization294K272K218K251K250K
EBITDA(6.38M)(7.18M)(13.96M)(11.97M)(11.44M)
EBITDA Margin-319.4%-430.7%-873.3%-523.5%-468.3%
Operating Income(6.66M)(8.45M)(11.42M)(12M)(11.69M)
Operating Margin-333.5%-506.7%-714.7%-524.8%-478.5%
Interest Income00005.39M
Interest Expense28K176K1.33M3.18M5.16M
Other Income / Expenses(40K)819K(4.09M)(3.4M)(36M)
Income Before Tax(6.96M)(7.63M)(15.51M)(15.4M)(47.69M)
Pre-Tax Margin-348.6%-457.6%-970.4%-673.4%-1952.9%
Income Tax Expense00000
Net Income(8.79M)(11.28M)(15.66M)(15.4M)(47.69M)
Net Margin-440.1%-676.7%-980.1%-673.8%-1953.0%
EPS (Basic)(0.03)(0.04)(0.06)(0.05)(0.17)
EPS (Diluted)(0.03)(0.04)(0.06)(0.05)(0.17)
Weighted Avg Shares252.46M269.84M278.56M281.08M287.21M
Weighted Avg Shares (Diluted)252.46M269.84M278.56M281.08M287.21M

Spectral Medical Inc.

TSX:EDT.TO

Intrinsic Alpha fair value

Locked

Current Price

$1.04

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.